T Baert
Overview
Explore the profile of T Baert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baert T, Vande Casteele T, Bouckaert F, Vandenbulcke M
Tijdschr Psychiatr
. 2024 Jan;
65(10):624-628.
PMID: 38174397
Background: Major depression is associated with activity and connectivity changes of multiple neural networks that correlate to the clinical manifestation. The chronic and recurrent course of late -life depression (LLD)...
2.
Baert T, Ferrero A, Sehouli J, ODonnell D, Gonzalez-Martin A, Joly F, et al.
Ann Oncol
. 2021 Mar;
32(6):710-725.
PMID: 33675937
Treatment approaches for relapsed ovarian cancer have evolved over the past decade from a calendar-based decision tree to a patient-oriented biologically driven algorithm. Nowadays, platinum-based chemotherapy should be offered to...
3.
Landolfo C, Achten E, Ceusters J, Baert T, Froyman W, Heremans R, et al.
Gynecol Oncol
. 2020 Sep;
159(3):811-819.
PMID: 32994054
Objective: To estimate the diagnostic value of tumor and immune related proteins in the discrimination between benign and malignant adnexal masses, and between different subgroups of tumors. Methods: In this...
4.
Baert T, Van Duppen Z, De Wachter D
Tijdschr Psychiatr
. 2020 Jan;
62(1):47-53.
PMID: 31994711
Researchers that try to identify the relationship between hope and mental health often lack a conceptual understanding of 'hope'. Nonetheless, experiences of despair that are central in depression seem to...
5.
Colombo N, Sessa C, Bois A, Ledermann J, McCluggage W, McNeish I, et al.
Int J Gynecol Cancer
. 2019 May;
29(4):728-760.
PMID: 31048403
The development of guidelines is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the mission...
6.
Colombo N, Sessa C, Bois A, Ledermann J, McCluggage W, McNeish I, et al.
Ann Oncol
. 2019 May;
30(5):672-705.
PMID: 31046081
The development of guidelines recommendations is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the...
7.
Coosemans A, Vankerckhoven A, Baert T, Boon L, Ruts H, Riva M, et al.
Eur J Cancer
. 2019 Apr;
113:41-44.
PMID: 30965214
Because of the failure of immunotherapy as single agent in a number of cancers, current clinical trials are focusing on combining immunotherapy with other therapies. The most frequently chosen combination...
8.
Baert T, Storme N, Van Nieuwenhuysen E, Uyttebroeck A, Van Damme N, Vergote I, et al.
Maturitas
. 2016 Apr;
88:3-8.
PMID: 27105689
Ovarian cancer is rare in childhood. This explains why there are only scattered reports on it in the literature and why there is a lack of specific pediatric treatment. This...
9.
Coosemans A, Baert T, Vergote I
Facts Views Vis Obgyn
. 2015 Apr;
7(1):73-8.
PMID: 25897374
Ovarian cancer is the second most important pelvic gynaecologic malignancy and nowadays still kills 80% of patients. New treatment options are mandatory. Although it has been shown that ovarian cancer...
10.
Baert T, Timmerman D, Vergote I, Coosemans A
Facts Views Vis Obgyn
. 2015 Apr;
7(1):67-72.
PMID: 25897373
Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based...